Asian Spectator

Times Advertising

Kazia Therapeutics Highlights New Clinical and Translational Findings Demonstrating Paxalisib's Ability to Reinvigorate Anti-Tumor Immunity Across Multiple Advanced Breast Cancer Populations including TNBC and HER2+

  • Written by PR Newswire Asia - Asian Spectator

First patient from TNBC trial demonstrated 76% tumor volume shrinkage with corresponding reductions in circulating tumor cells (CTC) and clusters

Reinvigoration of immune system + turning cold tumors hot

Preliminary ex-vivo data in HER2+ patients demonstrates immune reinvigoration and reductions in CTC and clusters

SYDNEY, Dec. 10, 2025 /PRNewswire/...

Magazine

Legal Risks Every Business Owner Should Know

Running a business in Australia comes with a degree of legal exposure that many owners underestimate until a problem is already at their door. From contractual disputes to employment matters, the le...

Jerat algoritma: AI perburuk beban ganda ojol dan kurir perempuan di Indonesia

● Sistem AI mengeksploitasi tenaga kerja informal melalui ekstraksi data dan pengalihan risiko kepada mereka.● Algoritma merugikan perempuan karena mengabaikan realitas beban domestik, isu...

Narasi “kebangkitan batu bara” bermunculan efek perang Iran, tapi data menunjukkan fakta sebaliknya

● Di tengah krisis energi global, data menunjukkan penggunaan batu bara dan gas justru turun, sementara energi terbarukan meningkat.● Tren penurunan ekspor baru bara di Indonesia sudah ter...